BDBM144762 US8952128, 21

SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1

InChI Key

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 144762   

TargetSomatostatin receptor type 2(Human)
Ipsen Pharma

US Patent
LigandPNGBDBM144762(US8952128, 21)
Affinity DataKi:  0.0200nM ΔG°:  -14.6kcal/molepH: 7.6 T: 25°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetD(2) dopamine receptor(Human)
Ipsen Pharma

US Patent
LigandPNGBDBM144762(US8952128, 21)
Affinity DataKi: >1.00E+3nMpH: 7.6Assay Description:The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...More data for this Ligand-Target Pair
In DepthDetails US Patent